{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 405783678
| IUPAC_name = 3-Propyl-7''H''-purine-2,6-dione
| image = Enprofylline.svg
| alt = Skeletal formula
| width = 140
| image2 = Enprofylline molecule spacefill.png
| alt2 = Space-filling model of enprofylline

<!--Clinical data-->
| tradename =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 41078-02-8
| ATC_prefix = None
| ATC_suffix =
| ATC_supplemental =
| PubChem = 1676
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00824
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 1613
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = DT7DT5E518
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D04006
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 126237
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 279898

<!--Chemical data-->
| C=8 | H=10 | N=4 | O=2 
| molecular_weight = 194.190 g/mol
| smiles = O=C2N(c1ncnc1C(=O)N2)CCC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SIQPXVQCUCHWDI-UHFFFAOYSA-N
}}

'''Enprofylline''' ('''3-propylxanthine''') is a [[xanthine]] derivative used in the treatment of [[asthma]], which acts as a [[bronchodilator]]. It acts primarily as a competitive nonselective [[phosphodiesterase inhibitor]] with relatively little activity as a nonselective [[adenosine receptor]] antagonist.<ref name="pmid6288396">{{cite journal |vauthors=Lunell E, Svedmyr N, Andersson KE, Persson CG |title=Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease |journal=European Journal of Clinical Pharmacology |volume=22 |issue=5 |pages=395–402 |year=1982 |pmid=6288396 |doi= 10.1007/bf00542541|url=}}</ref><ref name="pmid3325233">{{cite journal |author=Laursen LC |title=Anti asthmatic effects and pharmacokinetics of enprofylline--a new xanthine derivate |journal=Danish Medical Bulletin |volume=34 |issue=6 |pages=289–97 |date=December 1987 |pmid=3325233 |doi= |url=}}</ref>

==References==
{{reflist}}

{{Asthma and copd rx}}
{{Phosphodiesterase inhibitors}}
{{Adenosinergics}}

[[Category:Adenosine receptor antagonists]]
[[Category:Bronchodilators]]
[[Category:Phosphodiesterase inhibitors]]
[[Category:Xanthines]]